Hyperimmune Bovine Colostrum as a Novel Therapy to Combat Clostridium difficile Infection

Abstract

HBC provides an oral, cost-effective, and safe alternative to antibiotic therapy for CDI. By preserving intestinal microbiota, HBC may be more efficacious than antibiotics. Additional studies are warranted to establish HBC as a viable immunotherapeutic agent for human use against CDI.